| Dr Dakhaz R Mohammed, MD | |
|
391 Wallace Rd, 391 Wallace Rd, Nashville, TN 37211-4851 | |
| (615) 781-4000 | |
| (615) 332-6265 |
| Full Name | Dr Dakhaz R Mohammed |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 23 Years |
| Location | 391 Wallace Rd, Nashville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972764546 | NPI | - | NPPES |
| 1524739 | Medicaid | TN | |
| 103119160 | Other | TN | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 47527 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Thomas West Hospital | Nashville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Warner Physician Services Pc | 0345602801 | 46 |
| Hospital Medicine Services Of Tn Llc | 2365807633 | 203 |
News Archive
CardioNet, Inc., a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Company entered into a definitive merger agreement with Biotel, Inc. to acquire all of the outstanding shares of Biotel for $11 million, or $3.84 per share, before adjustments for working capital. In connection with the merger agreement, the parties entered into a settlement agreement to dismiss the outstanding litigation between them, which will be effective as of the close of the merger.
Almonds may still be considered one of the highest energy food sources but it's not about how much you bite off, instead it's about how much you chew, according to a July 14 panel discussion at the 2013 Institute of Food Technologists Annual Meeting & Food Expo- held at McCormick Place.
Researchers from Switzerland recently investigated humoral and cell-mediated immune responses to mRNA-based vaccines in patients undergoing treatment with CD20-B-cell depleting agents for autoimmune diseases, transplantation, or malignancy.
Cyberkinetics Inc has received U.S. Food and Drug Administration approval to begin a clinical trial in which four-square-millimetre chips will be placed beneath the skulls of paralyzed patients.
› Verified 8 days ago
| Entity Name | Saint Thomas Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437194669 PECOS PAC ID: 1557269354 Enrollment ID: O20031230000470 |
News Archive
CardioNet, Inc., a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Company entered into a definitive merger agreement with Biotel, Inc. to acquire all of the outstanding shares of Biotel for $11 million, or $3.84 per share, before adjustments for working capital. In connection with the merger agreement, the parties entered into a settlement agreement to dismiss the outstanding litigation between them, which will be effective as of the close of the merger.
Almonds may still be considered one of the highest energy food sources but it's not about how much you bite off, instead it's about how much you chew, according to a July 14 panel discussion at the 2013 Institute of Food Technologists Annual Meeting & Food Expo- held at McCormick Place.
Researchers from Switzerland recently investigated humoral and cell-mediated immune responses to mRNA-based vaccines in patients undergoing treatment with CD20-B-cell depleting agents for autoimmune diseases, transplantation, or malignancy.
Cyberkinetics Inc has received U.S. Food and Drug Administration approval to begin a clinical trial in which four-square-millimetre chips will be placed beneath the skulls of paralyzed patients.
› Verified 8 days ago
| Entity Name | Hospital Medicine Services Of Tn Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982301065 PECOS PAC ID: 2365807633 Enrollment ID: O20230421000177 |
News Archive
CardioNet, Inc., a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Company entered into a definitive merger agreement with Biotel, Inc. to acquire all of the outstanding shares of Biotel for $11 million, or $3.84 per share, before adjustments for working capital. In connection with the merger agreement, the parties entered into a settlement agreement to dismiss the outstanding litigation between them, which will be effective as of the close of the merger.
Almonds may still be considered one of the highest energy food sources but it's not about how much you bite off, instead it's about how much you chew, according to a July 14 panel discussion at the 2013 Institute of Food Technologists Annual Meeting & Food Expo- held at McCormick Place.
Researchers from Switzerland recently investigated humoral and cell-mediated immune responses to mRNA-based vaccines in patients undergoing treatment with CD20-B-cell depleting agents for autoimmune diseases, transplantation, or malignancy.
Cyberkinetics Inc has received U.S. Food and Drug Administration approval to begin a clinical trial in which four-square-millimetre chips will be placed beneath the skulls of paralyzed patients.
› Verified 8 days ago
| Entity Name | Warner Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770272221 PECOS PAC ID: 0345602801 Enrollment ID: O20230815002672 |
News Archive
CardioNet, Inc., a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Company entered into a definitive merger agreement with Biotel, Inc. to acquire all of the outstanding shares of Biotel for $11 million, or $3.84 per share, before adjustments for working capital. In connection with the merger agreement, the parties entered into a settlement agreement to dismiss the outstanding litigation between them, which will be effective as of the close of the merger.
Almonds may still be considered one of the highest energy food sources but it's not about how much you bite off, instead it's about how much you chew, according to a July 14 panel discussion at the 2013 Institute of Food Technologists Annual Meeting & Food Expo- held at McCormick Place.
Researchers from Switzerland recently investigated humoral and cell-mediated immune responses to mRNA-based vaccines in patients undergoing treatment with CD20-B-cell depleting agents for autoimmune diseases, transplantation, or malignancy.
Cyberkinetics Inc has received U.S. Food and Drug Administration approval to begin a clinical trial in which four-square-millimetre chips will be placed beneath the skulls of paralyzed patients.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dakhaz R Mohammed, MD 391 Wallace Rd, Tristar Southern Hills Medical Center, Nashville, TN 37211-4851 Ph: (615) 781-4000 | Dr Dakhaz R Mohammed, MD 391 Wallace Rd, 391 Wallace Rd, Nashville, TN 37211-4851 Ph: (615) 781-4000 |
News Archive
CardioNet, Inc., a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Company entered into a definitive merger agreement with Biotel, Inc. to acquire all of the outstanding shares of Biotel for $11 million, or $3.84 per share, before adjustments for working capital. In connection with the merger agreement, the parties entered into a settlement agreement to dismiss the outstanding litigation between them, which will be effective as of the close of the merger.
Almonds may still be considered one of the highest energy food sources but it's not about how much you bite off, instead it's about how much you chew, according to a July 14 panel discussion at the 2013 Institute of Food Technologists Annual Meeting & Food Expo- held at McCormick Place.
Researchers from Switzerland recently investigated humoral and cell-mediated immune responses to mRNA-based vaccines in patients undergoing treatment with CD20-B-cell depleting agents for autoimmune diseases, transplantation, or malignancy.
Cyberkinetics Inc has received U.S. Food and Drug Administration approval to begin a clinical trial in which four-square-millimetre chips will be placed beneath the skulls of paralyzed patients.
› Verified 8 days ago
Dr. Serena Vayda, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2312 Elliston Pl, Nashville, TN 37203 Phone: 201-618-4693 | |
Kimberlyn J Langley Brown, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4220 Harding Rd, Suite 500, Nashville, TN 37205 Phone: 615-222-6977 Fax: 615-222-5322 | |
Dr. Songmin Cai, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10 Knolls Pl, Knolls Place Medical Cilinc, Nashville, TN 37211 Phone: 615-457-1265 Fax: 615-457-1326 | |
Dr. Rima Mansour Shobar, M.B.B.CH Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4220 Harding Pike, Nashville, TN 37205 Phone: 614-222-2111 | |
Bryan Scott Overcarsh, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3443 Dickerson Pike Ste 680, Nashville, TN 37207 Phone: 615-865-3322 Fax: 615-467-6692 | |
Michael Douglas Mccann, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Brandon Stanley, AGACNP-C Hospitalist Medicare: Medicare Enrolled Practice Location: 3441 Dickerson Pike, Nashville, TN 37207 Phone: 615-769-2000 |